We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Must Review Decongestants' Effectiveness, Waxman Says
FDA Must Review Decongestants' Effectiveness, Waxman Says
September 1, 2006
The FDA needs to investigate the drug industry’s replacement of the active ingredient in certain widely used nasal decongestants to make sure these products are effective, Rep. Henry Waxman (D-Calif.) said in an Aug. 23 letter to the agency.